Merck (NYSE: MRK) reported Q4 EPS of $0.89, versus the consensus of $0.89. Revenue for the quarter came in at $10.1 billion, versus $10.22 billion consensus.

GUIDANCE:

Merck sees FY2017 EPS of $3.72-$3.87, versus the consensus of $3.85.

For earnings history and earnings-related data on Merck (MRK) click here.